Drug intelligence / Profile preview

Yinxie I Formula

Development stage
Preclinical
Lead developer
Ningxia Medical University
Administration
Topical
01

Overview

Yinxie I Formula is a traditional Chinese medicine (TCM) topical formulation developed by the Department of Dermatology at Ningxia Medical University for the treatment of psoriasis. It is composed of nine herbal ingredients: Sophora flavescens Aiton, Wild chrysanthemum, Common Cnidium Fruit, Angelica dahurica Benth, Rhei Radix et rhizome, Phellodendri Cortex, Fructus Kochiae, Acorus gramineus, and Alumen. The formula exerts its therapeutic effects by inhibiting the IL-23/IL-17 immune axis and the STAT3 signaling pathway, thereby reducing the expression of pro-inflammatory cytokines such as IL-6, IL-17A, IL-22, IL-23, and TNF-α. Research identifies Buddleoside (linarin) as a key active ingredient responsible for its anti-inflammatory and anti-proliferative activities against keratinocytes. It is used clinically as a topical decoction or concentrate to alleviate skin lesions, reduce inflammatory cell infiltration, and relieve itching in patients with psoriasis.

Other names
Yinxie 1 FormulaYinxie1 FormulaYinxie-1 FormulaYinxie No. 1 Formula
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)IL-23 (Interleukin-23)IL-17A (Interleukin-17A)

Beyond the preview

Go deeper on Yinxie I Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yinxie I Formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call